DUBLIN, Aug. 22, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences:
2023 Wells Fargo Healthcare Conference
Wednesday, September 6, 2023, at 12:00 p.m. EDT (11:00 a.m. CDT)
Geoff Martha, chairman and chief executive officer, will answer questions on the medtech industry and on the company.
Morgan Stanley 21st Annual Global Healthcare Conference
Monday, September 11, 2023, at 9:20 a.m. EDT (8:20 a.m. CDT)
Karen Parkhill, executive vice president & chief financial officer, IT & enterprise excellence, will answer questions on the company.
Bank of America Global Healthcare Conference 2023
Wednesday, September 13, 2023, at 3:55 p.m. BST (9:55a.m. CDT)
Geoff Martha, chairman & chief executive officer, will answer questions on the company.
A live webcast of each Q&A session will be available on the date and time of each of the conferences noted above by clicking on the Events link at http://investorrelations.medtronic.com. An archive of each Q&A session will be available on the same webpage later in the day.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Erika Winkels | Ryan Weispfenning |
Public Relations | Investor Relations |
+1-763-526-8478 | +1-763-505-4626 |
Last Trade: | US$82.60 |
Daily Volume: | 0 |
Market Cap: | US$105.730B |
February 24, 2025 February 18, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load